Orostachys japonicus Suppresses Osteoclast Differentiation by Inhibiting NFATc1 Expression.

about

Prevention and Treatment of Osteoporosis Using Chinese Medicinal Plants: Special Emphasis on Mechanisms of Immune Modulation.

P2860

Q55410884-4EF71256-F6F9-4DDB-B8D4-572ECB849973

P2860

Orostachys japonicus Suppresses Osteoclast Differentiation by Inhibiting NFATc1 Expression.

Item

http://www.wikidata.org/entity/Q54257142

description

2015 nî lūn-bûn

@nan

2015年の論文

@ja

2015年学术文章

@wuu

2015年学术文章

@zh-cn

2015年学术文章

@zh-hans

2015年学术文章

@zh-my

2015年学术文章

@zh-sg

2015年學術文章

@yue

2015年學術文章

@zh

2015年學術文章

@zh-hant

name

Orostachys japonicus Suppresse ...... Inhibiting NFATc1 Expression.

@en

Orostachys japonicus Suppresse ...... Inhibiting NFATc1 Expression.

@nl

type

Item

label

Orostachys japonicus Suppresse ...... Inhibiting NFATc1 Expression.

@en

Orostachys japonicus Suppresse ...... Inhibiting NFATc1 Expression.

@nl

prefLabel

Orostachys japonicus Suppresse ...... Inhibiting NFATc1 Expression.

@en

Orostachys japonicus Suppresse ...... Inhibiting NFATc1 Expression.

@nl

P1476

Orostachys japonicus Suppresse ...... Inhibiting NFATc1 Expression.

@en

P2093

Chung-Jo Lee

http://www.w3.org/2001/XMLSchema#string

Hyunil Ha

http://www.w3.org/2001/XMLSchema#string

Jin Yeul Ma

http://www.w3.org/2001/XMLSchema#string

Ki-Shuk Shim

http://www.w3.org/2001/XMLSchema#string

Taesoo Kim

http://www.w3.org/2001/XMLSchema#string

P2860

Identification of LRRc17 as a negative regulator of receptor activator of NF-kappaB ligand (RANKL)-induced osteoclast differentiation

Serum CTX: a new marker of bone resorption that shows treatment effect more often than other markers because of low coefficient of variability and large changes with bisphosphonate therapy

Osteoimmunology: shared mechanisms and crosstalk between the immune and bone systems

Curculigo orchioides, a traditional Chinese medicinal plant, prevents bone loss in ovariectomized rats.

Blimp1-mediated repression of negative regulators is required for osteoclast differentiation.

Therapeutic approaches to bone diseases.

Bone remodeling increases substantially in the years after menopause and remains increased in older osteoporosis patients.

RANK ligand and osteoprotegerin in myeloma bone disease.

Nuclear factor of activated T cells c is a target of p38 mitogen-activated protein kinase in T cells

Screening of Korean medicinal plants for possible osteoclastogenesis effects in vitro.

P304

1013-1030

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1142/S0192415X15500585

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2015-01-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

26205967

http://www.w3.org/2001/XMLSchema#string

Orostachys japonicus Suppresses Osteoclast Differentiation by Inhibiting NFATc1 Expression.

about

P2860

P2860

Orostachys japonicus Suppresses Osteoclast Differentiation by Inhibiting NFATc1 Expression.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P577

P698

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P577

P698